This study is looking at ways to better predict how well chemotherapy works for people with colorectal cancer. Researchers are studying tissue samples from your primary tumor using a method called SPLICE, which looks at RNA splicing (a process where genetic information is cut and pasted). The goal is to develop a computer model that can predict if chemotherapy will be effective and if your cancer is likely to return. You might be able to join if you are 18-80 years old, have stage II or III colorectal cancer, and have received standard chemotherapy after surgery. The main goal is to see how long people live without their cancer coming back (recurrence-free survival) for up to 60 months. The current status of this study is unclear.

Study design

This is an observational study, meaning researchers will collect and analyze information without giving you a new treatment. It plans to include 200 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your recurrence-free survival will be measured from the date of your disease treatment up to 60 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.